Insider · CIK 0001543209

Nicolette Charles A.

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001543209

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-25	ARGOS THERAPEUTICS INCD Disposition to Issuer	CSO and Vice President of R&D	DDisposition to Issuer	−27.2K sh	—	—	20,056
2018-03-28	ARGOS THERAPEUTICS INCA Award	CSO and Vice President of R&D	AAward	+27.2K sh	—	—	47,206
2018-01-03	ARGOS THERAPEUTICS INCS Sale	CSO and Vice President of R&D	SSale	−92K sh	$0.16	−$15.1K	500,240
2017-08-30	ARGOS THERAPEUTICS INCA Award	CSO and Vice President of R&D	AAward	+499K sh	—	—	592,241
2017-01-19	ARGOS THERAPEUTICS INCA Award	CSO and Vice President of R&D	AAward	+16.8K sh	—	—	92,796
2017-01-19	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	CSO and Vice President of R&D	AAward	+185K sh	—	—	185,000
2016-06-13	ARGOS THERAPEUTICS INCA Award	CSO and Vice President of R&D	AAward	+10.9K sh	—	—	76,043
2016-06-13	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	CSO and Vice President of R&D	AAward	+175K sh	—	—	175,000
2016-06-10	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	CSO and Vice President of R&D	AAward	+3,375 sh	—	—	3,375
2016-01-08	ARGOS THERAPEUTICS INCA Award	CSO and Vice President of R&D	AAward	+48.6K sh	—	—	63,117
2015-08-20	ARGOS THERAPEUTICS INCP Purchase	CSO and Vice President of R&D	PPurchase	+5,000 sh	$6.45	+$32.3K	13,130
2015-06-17	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	CSO and Vice President of R&D	AAward	+75K sh	—	—	75,000
2014-07-28	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	CSO and Vice President of R&D	AAward	+18K sh	—	—	297,803
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	CSO and Vice President of R&D	CConversion	+4,941 sh	—	—	4,941
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	CSO and Vice President of R&D	CConversion	+1,859 sh	—	—	6,800
2014-02-12	ARGOS THERAPEUTICS INCSeries D Preferred StockC Conversion	CSO and Vice President of R&D	CConversion	−4,941 sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries E Preferred StockC Conversion	CSO and Vice President of R&D	CConversion	−1,859 sh	—	—	0

Recent filings

Accepted (ET)
Apr 254
Nicolette Charles A.0001171843-18-003056
SEC(opens sec.gov)
Mar 304
Nicolette Charles A.0001171843-18-002392
SEC(opens sec.gov)
Jan 54
Nicolette Charles A.0001543209-18-000001
SEC(opens sec.gov)
Aug 314
Nicolette Charles A.0001543209-17-000002
SEC(opens sec.gov)
Jan 234
ARGOS THERAPEUTICS INC0001543209-17-000001
SEC(opens sec.gov)
Jun 144
ARGOS THERAPEUTICS INC0001543209-16-000004
SEC(opens sec.gov)
Jan 124
ARGOS THERAPEUTICS INC0001543209-16-000003
SEC(opens sec.gov)
Aug 274
ARGOS THERAPEUTICS INC0001543209-15-000002
SEC(opens sec.gov)
Jun 194
ARGOS THERAPEUTICS INC0001543209-15-000001
SEC(opens sec.gov)
Jul 304
ARGOS THERAPEUTICS INC0001543209-14-000001
SEC(opens sec.gov)
Feb 124
ARGOS THERAPEUTICS INC0001209191-14-009871
SEC(opens sec.gov)

Companies

ARGOS THERAPEUTICS INCCSO and Vice President of R&D

Address

C/O ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE

DURHAM, NC, 27704